Orgenesis Market Cap

Orgenesis has a market cap or net worth of $18.09 million as of March 31, 2025. Its market cap has decreased by -38.40% in one year.

Market Cap

18.09M

Enterprise Value

35.15M

Revenue

899.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

$2.32

Market Cap Chart

Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 18.09M, an increase of 7,052.40%. That is a compound annual growth rate of 33.77%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	18.09M	84.07%
Dec 31, 2024	9.83M	-38.42%
Dec 29, 2023	15.96M	-67.96%
Dec 30, 2022	49.81M	-28.75%
Dec 31, 2021	69.91M	-35.68%
Dec 31, 2020	108.70M	44.34%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.82B
SS Innovations International	1.76B
Nika Pharmaceuticals	1.02B
Veradigm	720.71M
Elite Pharmaceuticals	470.04M
Glass House Brands	371.89M
Northwest Biotherapeutics	318.00M
CytoDyn	288.56M

Market Cap Rankings